The French Society for Stem Cell Research (FSSCR) is a learned society intended to federate the French researchers on stem cells. It will be created at its first General Assembly to ...
READ MORE
Dear Colleague, Embryo development, cancer progression and tissue regeneration have in common a strong dependency on stem and progenitor cells. What are the shared characteristics and ...
READ MORE The opening day of the FSSCR be held at the Pasteur Institute, November 7, 2016. We thank Shahragim Tajbakhsh for his involvement in the organization of this event. The following ...
READ MORE 
INGESTEM, a National Infrastructure in Biology and Health certified by the "Plan Investissement d'Avenir" program (2012-2019), is the first French consortium of therapeutic innovations based on induced pluripotent stem cells (iPS cells) and human tissue engineering . Our ambition is to use the major potential of cellular reprogramming techniques to generate models of human diseases and regenerative medicine.
READ MORE
INGESTEM is open to academic, industrial and clinical research. It develops technologies on embryonic stem cells and iPS cells to discover and validate new therapeutic concepts. Academic and industrial R&D collaborations with the INGESTEM teams are avalaible, as well as on demand services and training.
READ MORE
